These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2775609)

  • 21. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the impact of telepharmacy.
    Schneider PJ
    Am J Health Syst Pharm; 2013 Dec; 70(23):2130-5. PubMed ID: 24249763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
    Generali JA; Danish MA; Rosenbaum SE
    Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacy service practice in a Chinese tertiary hospital.
    Chen B; Huang JJ; Chen HF; Xu BM
    Drug Metab Pers Ther; 2015 Dec; 30(4):215-30. PubMed ID: 26457791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. System for voluntary reporting of adverse drug reactions in a university hospital.
    Vorce-West TE; Barstow L; Butcher B
    Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reaction reporting: a working system.
    Michelson PA; Shields K
    Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a database computer program to identify trends in reporting of adverse drug reactions.
    Johnston PE; Morrow JD; Branch RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a videotape on adverse drug reactions.
    Morgan SA; Frank JT
    Am J Hosp Pharm; 1990 Jun; 47(6):1340-2. PubMed ID: 1695062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group.
    Emerson A; Martin RM; Tomlin M; Mann RD
    Pharmacoepidemiol Drug Saf; 2001; 10(2):95-103. PubMed ID: 11499859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of outpatient interventions made at an ambulatory cancer centre oncology pharmacy in Singapore.
    Chew C; Chiang J; Yeoh TT
    J Oncol Pharm Pract; 2015 Apr; 21(2):93-101. PubMed ID: 24477774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.
    Blix HS; Viktil KK; Moger TA; Reikvam A
    Pharm World Sci; 2006 Jun; 28(3):152-8. PubMed ID: 17004023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel scheme for the reporting of adverse drug reactions.
    Clarkson A; Ingleby E; Choonara I; Bryan P; Arlett P
    Arch Dis Child; 2001 Apr; 84(4):337-9. PubMed ID: 11259235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
    Smith CC; Bennett PM; Pearce HM; Harrison PI; Reynolds DJ; Aronson JK; Grahame-Smith DG
    Br J Clin Pharmacol; 1996 Oct; 42(4):423-9. PubMed ID: 8904613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.